Abstract
Randomised controlled trials (RCTs) are regarded as the gold standard method for evaluating an intervention and its outcome and have the ability to evaluate the cost-effectiveness of an intervention. This form of research is known to be the most rigorous study design in order to determine a cause-effect relationship. This chapter summarises the randomised controlled trial design methodology, what key features should be present and its advantages and limitations. The place of cluster randomised controlled trials within health services research and in particular pharmacy practice research (PPR) will also be discussed.
PPR has been described extensively in the literature and within other chapters within this book. PPR has evolved through the years, and the number of RCTs within PPR has increased significantly since 2000. This chapter also details examples of recent RCTs within PPR and makes recommendations for future research within this field.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Akobeng A. Understanding randomised controlled trials. Arch Dis Child. 2005;90(8):840–4.
Altman DG. Randomisation. BMJ. 1991;302(6791):1481–2.
Altman DG, Bland JM. How to randomise. BMJ (Clinical Research Ed). 1999;319(7211):703–4.
Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134(8):663–94.
Avorn J, Soumerai SB, Everitt DE, Ross-Degnan D, Beers MH, Sherman D, et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med. 1992;327(3):168–73.
Awaisu A, Alsalimy N, Pharmacy A. Pharmacists’ involvement in and attitudes toward pharmacy practice research: a systematic review of the literature. Res Social Adm Pharm. 2015;11(6):725–48.
Babar Z, Vitry A. Differences in Australian and New Zealand medicines funding policies. Aust Prescr. 2014;37:150–1.
Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276(8):637–9.
Bond C. The need for pharmacy practice research. Int J Pharm Pract. 2006;14:1–2.
Bond C. Pharmacy practice research: evidence and impact. In: Pharmacy practice research methods. New York: Springer; 2015. p. 1–24.
Carter BL. Designing quality health services research: why comparative effectiveness studies are needed and why pharmacists should be involved. Pharmacotherapy. 2010;30(8):751–7.
Carter BL, Foppe van Mil JW. Comparative effectiveness research: evaluating pharmacist interventions and strategies to improve medication adherence. Am J Hypertens. 2010;23(9):949–55.
Charrois TL, Durec T, Tsuyuki RT. Systematic reviews of pharmacy practice research: methodologic issues in searching, evaluating, interpreting, and disseminating results. Ann Pharmacother. 2009;43(1):118–22.
Chisholm-Burns MA, Lee JK, Spivey CA, Slack M, Herrier RN, Hall-Lipsy E, et al. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48:923–33.
Choudhry NK, Isaac T, Lauffenburger JC, Gopalakrishnan C, Lee M, Vachon A, et al. Effect of a remotely delivered tailored multicomponent approach to enhance medication taking for patients with hyperlipidemia, hypertension, and diabetes: the STIC2IT cluster randomized clinical trial. JAMA Intern Med. 2018;178(9):1182–9.
Correr CJ, Melchiors AC, de Souza TT, Rotta I, Salgado TM, Fernandez-Llimos F. A tool to characterize the components of pharmacist interventions in clinical pharmacy services: the DEPICT project. Ann Pharmacother. 2013;47(7–8):946–52.
Crotty M, Halbert J, Rowett D, Giles L, Birks R, Williams H, et al. An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing. 2004;33(6):612–7.
Crotty M, Whitehead C, Rowett D, Halbert J, Weller D, Finucane P, et al. An outreach intervention to implement evidence based practice in residential care: a randomized controlled trial [ISRCTN67855475]. BMC Health Serv Res. 2004;4(1):6.
Cummings SR, Hulley SB. Designing clinical research: an epidemiologic approach. Philadelphia: Williams & Wilkins; 1988.
de Barra M, Scott CL, Scott NW, Johnston M, de Bruin M, Nkansah N, et al. Pharmacist services for non-hospitalised patients. Cochrane Database Syst Rev. 2018;(9):CD013102.
Fish A, Watson MC, Bond CM. Practice-based pharmaceutical services: a systematic review. Int J Pharm Pract. 2002;10(4):225–33.
Flanagan PS, Barns A. Current perspectives on pharmacist home visits: do we keep reinventing the wheel? Integr Pharm Res Pract. 2018;7:141.
Freedman K, Back S, Bernstein J. Sample size and statistical power of randomised, controlled trials in orthopaedics. J Bone Joint Surg Br. 2001;83(3):397–402.
Gilbert JH, Yan J, Hoffman SJ. A WHO report: framework for action on Interprofessional education and collaborative practice. J Allied Health. 2010;39(3):196–7.
Green BB, Cook AJ, Ralston JD, Fishman PA, Catz SL, Carlson J, et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299(24):2857–67.
Guerrera F, Renaud S, Tabbò F, Filosso PL. How to design a randomized clinical trial: tips and tricks for conduct a successful study in thoracic disease domain. J Thorac Dis. 2017;9(8):2692–6.
Gums T, Carter B, Foster E. Cluster randomized trials for pharmacy practice research. Int J Clin Pharm. 2016;38(3):607–14.
Hannan EL. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations. JACC Cardiovasc Interv. 2008;1(3):211–7.
Healthdirect Australia. Home medicines review. Available from: https://www.healthdirect.gov.au/home-medicines-review
Hemming K, Eldridge S, Forbes G, Weijer C, Taljaard M. How to design efficient cluster randomised trials. BMJ. 2017;358:j3064.
Hendrie D, Miller TR, Woodman RJ, Hoti K, Hughes J. Cost-effectiveness of reducing glycaemic episodes through community pharmacy management of patients with type 2 diabetes mellitus. J Prim Prev. 2014;35(6):439–49.
Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–43.
Hickman LD, Phillips JL, Newton PJ, Halcomb EJ, Al Abed N, Davidson PM. Multidisciplinary team interventions to optimise health outcomes for older people in acute care settings: a systematic review. Arch Gerontol Geriatr. 2015;61(3):322–9.
Hogg W, Lemelin J, Dahrouge S, Liddy C, Armstrong CD, Legault F, et al. Randomized controlled trial of anticipatory and preventive multidisciplinary team care: for complex patients in a community-based primary care setting. Can Fam Physician. 2009;55(12):e76–85.
Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A, et al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ. 2005;330(7486):293.
Jodar-Sanchez F, Malet-Larrea A, Martin JJ, Garcia-Mochon L, Lopez Del Amo MP, Martinez-Martinez F, et al. Cost-utility analysis of a medication review with follow-up service for older adults with polypharmacy in community pharmacies in Spain: the conSIGUE program. PharmacoEconomics. 2015;33(6):599–610.
Jorgenson D, Lamb D, MacKinnon N. Practice change challenges and priorities: a national survey of practising pharmacists. Can Pharm J. 2011;144(3):125–31.
Karanicolas PJ, Farrokhyar F, Bhandari M. Practical tips for surgical research: blinding: who, what, when, why, how? Can J Surg. 2010;53(5):345–8.
Koshman SL, Blais J. What is pharmacy research? Can J Hosp Pharm. 2011;64(2):154.
Lauer MS, Topol EJ. Clinical trials—multiple treatments, multiple end points, and multiple lessons. JAMA. 2003;289(19):2575–7.
Loganathan M, Singh S, Franklin BD, Bottle A, Majeed A. Interventions to optimise prescribing in care homes: systematic review. Age Ageing. 2011;40(2):150–62.
MacKeigan LD, Nissen LM. Clinical pharmacy services in the home. Dis Manag Health Out. 2008;16(4):227–44.
Malet-Larrea A, Goyenechea E, Garcia-Cardenas V, Calvo B, Arteche JM, Aranegui P, et al. The impact of a medication review with follow-up service on hospital admissions in aged polypharmacy patients. Br J Clin Pharmacol. 2016;82(3):831–8.
Manfrin A, Tinelli M, Thomas T, Krska J. A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients. BMC Health Serv Res. 2017;17(1):300.
Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Groen SE, Kadrmas HM, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2013;310(1):46–56.
Moher D, Dulberg CS, Wells GAJJ. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA. 1994;272(2):122–4.
MRC AJMRC. Framework for the development and evaluation of RCTs for complex interventions to improve health. 2000.
Mulder R, Singh AB, Hamilton A, Das P, Outhred T, Morris G, et al. The limitations of using randomised controlled trials as a basis for developing treatment guidelines. Evid Based Ment Health. 2018;21(1):4–6.
Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM, et al. Effect of outpatient pharmacists’ non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev. 2010;(7):CD000336.
Raebel MA, Charles J, Dugan J, Carroll NM, Korner EJ, Brand DW, et al. Randomized trial to improve prescribing safety in ambulatory elderly patients. J Am Geriatr Soc. 2007;55(7):977–85.
Riordan DO, Walsh KA, Galvin R, Sinnott C, Kearney PM, Byrne S. The effect of pharmacist-led interventions in optimising prescribing in older adults in primary care: a systematic review. SAGE Open Med. 2016;4:2050312116652568.
Rosner B. Fundamentals of biostatistics. Canada: Nelson Education; 2015.
Rotta I, Souza TT, Salgado TM, Correr CJ, Fernandez-Llimos F, Pharmacy A. Characterization of published randomized controlled trials assessing clinical pharmacy services around the world. Res Social Adm Pharm. 2017;13(1):201–8.
Salgado TM, Moles R, Benrimoj SI, Fernandez-Llimos F. Pharmacists’ interventions in the management of patients with chronic kidney disease: a systematic review. Nephrol Dial Transplant. 2011;27(1):276–92.
Scahill S, Nagaria RA, Curley LE. The future of pharmacy practice research–Perspectives of academics and practitioners from Australia, NZ, United Kingdom, Canada and USA. Res Social Adm Pharm. 2018;14(12):1163–71.
Schmidt I, Claesson CB, Westerholm B, Nilsson LG, Svarstad BL. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc. 1998;46(1):77–82.
Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273(5):408–12.
Schulz KF, Grimes DA. Blinding in randomised trials: hiding who got what. Lancet (London, England). 2002;359(9307):696–700.
Sibbald B, Roland M. Understanding controlled trials: Why are randomised controlled trials important? BMJ. 1998;316(7126):201.
Stewart S, Marley JE, Horowitz JD. Effects of a multidisciplinary, home-based intervention on planned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study. Lancet. 1999;354(9184):1077–83.
Stewart S, Pearson S, Horowitz JD. Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. Arch Intern Med. 1998;158(10):1067–72.
Tan ECK, Stewart K, Elliott RA, George J. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Soc Adm Pharm. 2014;10(4):608–22.
Thamby SA, Subramani PJ. Seven-star pharmacist concept of WHO. J Young Pharm. 2014;6(2):1.
Tsuyuki RT. Designing pharmacy practice research trials. Can J Hosp Pharm. 2014;67(3):226.
Turnheim K. Drug therapy in the elderly. Exp Gerontol. 2004;39(11–12):1731–8.
Vetter TR. Magic mirror, on the wall—which is the right study design of them all?—Part I. Anesth Analg. 2017;124(6):2068–73.
Wallerstedt SM, Kindblom JM, Nylén K, Samuelsson O, Strandell A. Medication reviews for nursing home residents to reduce mortality and hospitalization: systematic review and meta-analysis. Br J Clin Pharmacol. 2014;78(3):488–97.
Winslade N, Eguale T, Tamblyn R. Optimising the changing role of the community pharmacist: a randomised trial of the impact of audit and feedback. BMJ Open. 2016;6(5):e010865.
World Health Organization. Working for health and growth: investing in the health workforce. 2016a.
World Health Organization. Global strategy on human resources for health: Workforce 2030. 2016b.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Curley, L.E., Lin, J.C. (2020). Randomised Controlled Trials and Pharmacy Practice Research. In: Babar, ZUD. (eds) Pharmacy Practice Research Methods. Springer, Singapore. https://doi.org/10.1007/978-981-15-2993-1_10
Download citation
DOI: https://doi.org/10.1007/978-981-15-2993-1_10
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-2992-4
Online ISBN: 978-981-15-2993-1
eBook Packages: MedicineMedicine (R0)